Investigation of the temporal trajectories of currently used neuropsychological tests is critical to identifying earliest changing measures on the path to dementia due to Alzheimer\u27s disease (AD). We used the Progression Score (PS) method to characterize the temporal trajectories of measures of verbal memory, executive function, attention, processing speed, language, and mental state using data spanning normal cognition, mild cognitive impairment (MCI), and AD from 1661 participants with a total of 7839 visits (age at last visit 77.6 SD 9.2) in the Baltimore Longitudinal Study of Aging and 1542 participants with a total of 4467 visits (age at last visit 59.9 SD 7.3) in the Wisconsin Registry for Alzheimer\u27s Prevention. This method ali...
Significant progress has been made in characterizing the biological changes occurring in preclinical...
This study investigated the predictive value of the early progression rate of Alzheimer's disease on...
Abstract. We investigated the earliest neuropsychological changes in Alzheimer’s disease (AD) by com...
Investigation of the temporal trajectories of currently used neuropsychological tests is critical to...
Background: The characterizing symptom of Alzheimer disease (AD) is cognitive deterioration. While m...
Background: We investigated the pattern of disease progression in the asymptomatic, mild cognitive i...
Several neuropsychological tests and biomarkers of Alzheimer's disease (AD) have been validated and ...
Background: Alzheimer’s disease (AD) is now understood to have a long preclinical phase in which pat...
Background: Neuropsychological tests that can track changes in cognitive functions after diagnosis o...
Objective: This study measured the annual rate ofcognitive change in patients with Alzhei-mer’s dise...
AbstractIntroductionBiomarker progressions explain higher variability in cognitive decline than base...
Objective: Alzheimer's disease (AD) studies are increasingly targeting earlier (pre)clinical populat...
Alzheimer's disease (AD) is a neurodegenerative condition that leads to dementia, and remains incura...
Background: Different rates of cognitive progression have been observed among Alzheimer disease (AD...
ObjectiveTo characterize the shape of the trajectories of Alzheimer disease biomarkers as a function...
Significant progress has been made in characterizing the biological changes occurring in preclinical...
This study investigated the predictive value of the early progression rate of Alzheimer's disease on...
Abstract. We investigated the earliest neuropsychological changes in Alzheimer’s disease (AD) by com...
Investigation of the temporal trajectories of currently used neuropsychological tests is critical to...
Background: The characterizing symptom of Alzheimer disease (AD) is cognitive deterioration. While m...
Background: We investigated the pattern of disease progression in the asymptomatic, mild cognitive i...
Several neuropsychological tests and biomarkers of Alzheimer's disease (AD) have been validated and ...
Background: Alzheimer’s disease (AD) is now understood to have a long preclinical phase in which pat...
Background: Neuropsychological tests that can track changes in cognitive functions after diagnosis o...
Objective: This study measured the annual rate ofcognitive change in patients with Alzhei-mer’s dise...
AbstractIntroductionBiomarker progressions explain higher variability in cognitive decline than base...
Objective: Alzheimer's disease (AD) studies are increasingly targeting earlier (pre)clinical populat...
Alzheimer's disease (AD) is a neurodegenerative condition that leads to dementia, and remains incura...
Background: Different rates of cognitive progression have been observed among Alzheimer disease (AD...
ObjectiveTo characterize the shape of the trajectories of Alzheimer disease biomarkers as a function...
Significant progress has been made in characterizing the biological changes occurring in preclinical...
This study investigated the predictive value of the early progression rate of Alzheimer's disease on...
Abstract. We investigated the earliest neuropsychological changes in Alzheimer’s disease (AD) by com...